Unibest 优贝德
← Back to patent-cliff list

CAS 2730017-96-4

(4S,5S)-4-[(1S,6S)-6-(Benzyloxy)-2-bromo-1,3-dimethylcyclohex-2-en-1-yl]-2,2-dimethyl-5-(6,6,8-trimethyl-1,4-dithiaspiro[4.5]dec-7-en-7-yl)-1,3-dioxolane

Codes:(IX)101438-71-a

Application context (from source-drug indications)

乳腺癌Paclitaxel/Encequidar mesylate腺癌Paclitaxel/Encequidar mesylate血管肉瘤Paclitaxel/Encequidar mesylate实体瘤Paclitaxel/Encequidar mesylate

Source drugs (routes using this intermediate)

DrugTierExpiry
Paclitaxel/Encequidar mesylatePaclitaxel/Encequidar mesylateTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Paclitaxel/Encequidar mesylate优化路线steps: 11total yield: /

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.